Crossref
SURVIVAL OUTCOMES IN BORDERLINE RESECTABLE VS. LOCALLY ADVANCED PANCREATIC CANCER: THE ROLE OF TREATMENT SELECTION
HPB · 2026 · 28 · S181
DOI: 10.1016/j.hpb.2026.04.301 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2026. Verfasst von V.E. Galimberti und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Galimberti, V., Franco, J., Hidalgo, C., Levine, J., Habib, J., Rompen, I., Hewitt, D., Morgan, K., Wolfgang, C., Kluger, M., Sacks, G., & Javed, A. (2026). SURVIVAL OUTCOMES IN BORDERLINE RESECTABLE VS. LOCALLY ADVANCED PANCREATIC CANCER: THE ROLE OF TREATMENT SELECTION. HPB, 28, S181. https://doi.org/10.1016/j.hpb.2026.04.301
Vancouver
Galimberti V, Franco J, Hidalgo C, Levine J, Habib J, Rompen I, et al. SURVIVAL OUTCOMES IN BORDERLINE RESECTABLE VS. LOCALLY ADVANCED PANCREATIC CANCER: THE ROLE OF TREATMENT SELECTION. HPB. 2026;28:S181. doi:10.1016/j.hpb.2026.04.301
BibTeX
@article{Galimberti2026,
author = {Galimberti, V.E. and Franco, J.C. and Hidalgo, C.S. and Levine, J. and Habib, J.R. and Rompen, I.F. and Hewitt, D.B. and Morgan, K.A. and Wolfgang, C.L. and Kluger, M.D. and Sacks, G.D. and Javed, A.A.},
title = {SURVIVAL OUTCOMES IN BORDERLINE RESECTABLE VS. LOCALLY ADVANCED PANCREATIC CANCER: THE ROLE OF TREATMENT SELECTION},
journal = {HPB},
year = {2026},
volume = {28},
pages = {S181},
doi = {10.1016/j.hpb.2026.04.301}
}
EUVIMED